Skip to main content
S 649 112th Congress Senate

Scleroderma Research and Awareness Act

Official title: A bill to expand the research and awareness activities of the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the Centers for Disease… Show full official titleShow less

Official title: A bill to expand the research and awareness activities of the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the Centers for Disease Control and Prevention with respect to scleroderma, and for other purposes.

Introduced: June 6, 2012 Introduced by: Gillibrand, Kirsten E. Democratic · New York See on congress.gov
Health Government information and archivesHealth information and medical recordsHealth programs administration and fundingImmunology and vaccination
More subjectsShow fewer subjects
Medical researchMusculoskeletal and skin diseasesResearch administration and funding
Sign in to write a letter Sign in to watch
This bill died when the 112th Congress ended
It never became law before the 112th Congress (2011–2012) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 17, 2011
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mar 17, 2011
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action March 17, 2011

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Plain-English summary Congressional Research Service

Scleroderma Research and Awareness Act - Requires the Director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases to expand, intensify, and coordinate the Institute's activities with respect to scleroderma, with particular emphasis on: (1) research focused on the etiology of scleroderma and the development of new treatment options, (2) clinical research to evaluate new treatment options, (3) basic research on the relationship between scleroderma and secondary conditions, (4) establishment of scleroderma patient registries, and (5) support for training of new clinicians and investigators with expertise in scleroderma.

Directs the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to carry out an educational campaign to increase public awareness of scleroderma.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 2
All 2 Democratic 2
D
Blumenthal, Richard
Connecticut · Jun 6, 2012
 D
Schumer, Charles E.
New York · May 23, 2011
Cite this page click to expand
APA
U.S. Congress. (2026). S. 649: Scleroderma Research and Awareness Act. 112th Congress. Open America. https://openamerica.io/bill/112-S-649/
MLA
"S. 649: Scleroderma Research and Awareness Act." 112th Congress, 2026, Open America, https://openamerica.io/bill/112-S-649/.
Bluebook (legal)
S. 649, 112th Cong. (2026), https://openamerica.io/bill/112-S-649/.
Markdown link
[S. 649: Scleroderma Research and Awareness Act](https://openamerica.io/bill/112-S-649/)
Report a problem